These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 4553733)

  • 1. Cyclophosphamide. Drug interactions and bone marrow transplantation.
    Kovacs K; Steinberg AD
    Transplantation; 1972 Mar; 13(3):316-21. PubMed ID: 4553733
    [No Abstract]   [Full Text] [Related]  

  • 2. [Trial of allogenic bone marrow graft in rats after conditioning with cyclophosphamide].
    Kolar V; Kolarova M
    Rev Fr Etud Clin Biol; 1969 Oct; 14(8):780-2. PubMed ID: 4904576
    [No Abstract]   [Full Text] [Related]  

  • 3. Immunological considerations of bone marrow transplantation.
    Uphoff DE
    Transplant Proc; 1969 Mar; 1(1):39-43. PubMed ID: 4944248
    [No Abstract]   [Full Text] [Related]  

  • 4. Mechanism of augmented graft survival in mice after ALS and bone marrow infusion.
    Wood ML; Heppner G; Gozzo JJ; Monaco AP
    Transplant Proc; 1973 Mar; 5(1):691-6. PubMed ID: 4572128
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of antilymphocyte serum on the thymus.
    Levey RH; Taub R
    Transplant Proc; 1969 Mar; 1(1):424-8. PubMed ID: 4944253
    [No Abstract]   [Full Text] [Related]  

  • 6. [Bone marrow regulatory factors (BMRF) and the transplanting of bone marrow: a model of morphostasis and immunity].
    Pierpaoli W; Maestroni GJ
    Fiziol Cheloveka; 1984; 10(2):234-41. PubMed ID: 6398233
    [No Abstract]   [Full Text] [Related]  

  • 7. [Restoration of immunologic reactivity to tolerant or cyclophosphamide treated mice by administration of syngenous thymus cells].
    Pevnitskiĭ LA
    Biull Eksp Biol Med; 1973 Apr; 75(4):62-6. PubMed ID: 4614873
    [No Abstract]   [Full Text] [Related]  

  • 8. In vitro modification of donor bone marrow used to produce enhanced graft survival in antilymphocyte serum (ALS)-treated mice.
    Gozzo JJ; Wood ML; Pompei R; Monaco AP
    Transplant Proc; 1973 Mar; 5(1):853-6. PubMed ID: 4572148
    [No Abstract]   [Full Text] [Related]  

  • 9. Survival of rat bone marrow cells after treatment with myleran and endoxan.
    Dunjic A; Cuvelier AM
    Exp Hematol; 1973; 1(1):11-21. PubMed ID: 4608438
    [No Abstract]   [Full Text] [Related]  

  • 10. [Heterotopic bone marrow transplantation in tolerant animals].
    Kuralesova AI
    Biull Eksp Biol Med; 1970 Jul; 70(7):97-100. PubMed ID: 4925759
    [No Abstract]   [Full Text] [Related]  

  • 11. The effect of busulphan on the pharmacokinetics of cyclophosphamide and its 4-hydroxy metabolite: time interval influence on therapeutic efficacy and therapy-related toxicity.
    Hassan M; Ljungman P; Ringdén O; Hassan Z; Oberg G; Nilsson C; Békassy A; Bielenstein M; Abdel-Rehim M; Georén S; Astner L
    Bone Marrow Transplant; 2000 May; 25(9):915-24. PubMed ID: 10800057
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Isogeneic bone marrow transplantation in rats previously treated with cyclophosphamide (preliminary report)].
    Hernández P; Carmena A; Callejas J
    Rev Clin Esp; 1972 Mar; 124(6):587-90. PubMed ID: 4602405
    [No Abstract]   [Full Text] [Related]  

  • 13. Induction of stable long-term mixed hematopoietic chimerism following nonmyeloablative conditioning with T cell-depleting antibodies, cyclophosphamide, and thymic irradiation leads to donor-specific in vitro and in vivo tolerance.
    Mapara MY; Pelot M; Zhao G; Swenson K; Pearson D; Sykes M
    Biol Blood Marrow Transplant; 2001; 7(12):646-55. PubMed ID: 11787527
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bone marrow transplantation in children.
    Dooren LJ; Kamphuis RP; de Koning J; Vossen JM
    Semin Hematol; 1974 Jul; 11(3):369-82. PubMed ID: 4599790
    [No Abstract]   [Full Text] [Related]  

  • 15. Cyclophosphamide regimens in rhesus monkey with and without marrow infusion.
    Storb R; Buckner CD; Dillingham LA; Thomas ED
    Cancer Res; 1970 Aug; 30(8):2195-203. PubMed ID: 4990004
    [No Abstract]   [Full Text] [Related]  

  • 16. Cyclophosphamide and antithymocyte globulin conditioning may be sufficient for Korean patients with early stage severe aplastic anemia transplanted with marrow from donors other than HLA-identical siblings.
    Lee JH; Lee JH; Lee JS; Kim WK; Chi HS; Lee KH
    Haematologica; 2001 Apr; 86(4):434-5. PubMed ID: 11325653
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyclophosphamide-induced immunologic tolerance to skin homografts.
    Nirmul G; Severin C; Taub RN
    Surg Forum; 1971; 22():287-8. PubMed ID: 4941317
    [No Abstract]   [Full Text] [Related]  

  • 18. Transient graft-versus-host reaction in the treatment of leukemia in mice.
    Boranić M
    J Natl Cancer Inst; 1968 Aug; 41(2):421-37. PubMed ID: 4876445
    [No Abstract]   [Full Text] [Related]  

  • 19. Co-transplantation of bone marrow stromal cells transduced with IL-7 gene enhances immune reconstitution after allogeneic bone marrow transplantation in mice.
    Li A; Zhang Q; Jiang J; Yuan G; Feng Y; Hao J; Li C; Gao X; Wang G; Xie S
    Gene Ther; 2006 Aug; 13(15):1178-87. PubMed ID: 16598299
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Dynamics of elaboration of immunologic memory to transplantation antigens].
    Bogdanov AP
    Biull Eksp Biol Med; 1972 Sep; 73(9):70-4. PubMed ID: 4565031
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.